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Abstract: Multistep chromatographic separations of the chloroform extract of the Turkish endemic
plant Psephellus pyrrhoblepharus (Boiss.) Wagenitz (syn. Centaurea pyrrhoblephara Boiss.) resulted
in the isolation of six guaianolid-type sesquiterpenes, chlorojanerin (1), 19-deoxychlorojanerin
(2), 15-hydroxyjanerin (3), aguerin B (4), cynaropicrin (5), eleganin (6); three flavonoids,
apigenin, 6-methoxyluteolin and jaceosidine; two glycosides, benzyl-1-O-β-d-glucoside and
3(Z)-hexenyl-1-O-β-d-glucoside; and the coumarin scopoletin. The structures were established
by the interpretation of their ESI-MS and 1D and 2D NMR data including 1H-NMR, JMOD,
1H,1H-COSY, HSQC, HMBC, and NOESY experiments. All compounds were isolated for the first
time from P. pyrrhoblepharus. Compounds 1–6, the isolated flavonoids and scopoletin were evaluated
for their antiproliferative activities on human gynecological cancer cell lines (SiHa, HeLa, and
MDA-MB-231 cells) using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
assay. Chlorojanerin (1), 19-deoxychlorojanerin (2), aguerin B (4), cynaropicrin (5), eleganin (6) were
shown to have noteworthy effects on all of the tested cell lines, while apigenin, jaceosidine, and
6-methoxyluteolin were moderately active on HeLa cells. The highest activities were demonstrated by
the chlorine-containing derivatives chlorojanerin (1) and 19-deoxychlorojanerin (2) with IC50 values
of 2.21 and 2.88 µM, respectively, against the triple negative breast cancer model MDA-MB-231 cells.
Keywords: Psephellus pyrrhoblepharus; Asteraceae; sesquiterpene lactones; chlorojanerin;
19-deoxychlorojanerin; gynecological cancer cells; antiproliferative activity
1. Introduction
The genus Psephellus Cass., belonging to the Asteraceae family, tribe Cynareae, includes
approximately 80 species. In Turkey, this genus is represented by 32 species. Some of these are
new members of the genus as some sections of the genus Centaurea have been transferred into the genus
Psephellus in recent years. Psephellus pyrrhoblepharus (Boiss.) Wagenitz (syn. Centaurea pyrrhoblephara
Boiss.) is an endemic plant of Turkey, and grows in the Middle and East Black Sea Region, Upper Red
River Area, and Upper Fırat Area of the country [1–3]. Psephellus species such as P. appendicigerus,
P. erzincani, and P. karduchorum have been used in traditional medicine as wound healing agents and in
the treatment of abscesses [4–7]. Basal leaves of P. karduchorum have been used as foodstuff and eaten
in fresh form [6].
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A systematic survey of plants used against cancer by J. Hartwell reported that some species of
the tribe Cynareae (Carduus acanthoides, Cynara scolymus, Cirsium acarna. C. ferox, Arctium lappa, A.
minus, Centaurea acaulis, C. calcitrapa, C. centaurium, C. cyanus, C. monantha, C. nigra, C. salonitana,
and C. scabiosa) were applied against cold tumors, carcinomas, tumors of the eye and throat, uterine
fibroids, and induration of spleen and liver in the form of decoctions, plasters, liniments, and pastes [8].
Ethnopharmacological studies have revealed that Centaurea ornata and C. repens have been used
in the treatment of cancer-related diseases [9,10]. A wide range of pharmacological studies have
been carried out on Centaurea, Arctium, Cirsium, and Psephellus species to examine their antitumor
activities, and significant cell proliferation inhibitory properties have been demonstrated in many
cases [11–13]. Bioactivity-guided phytochemical investigations on the active extracts revealed that, in
general, the presence of sesquiterpene lactones, flavonoids, and lignans as compounds responsible for
the antiproliferative effects [14–16].
The genus Psephellus was previously reported to be a rich source of sesquiterpenes and
lignans [17,18]; moreover P. pyrrhoblepharus was published to accumulate essential oil, containing
monoterpene and sesquiterpene hydrocarbons, and carbonylic compounds in substantial quantities [19].
The present study aimed at the phytochemical profiling of the Turkish endemic plant
P. pyrrhoblepharus, with special focus on the non-volatile compounds with antitumor potency. Multistep
chromatographic separation of the chloroform extract of the aerial plant parts was carried out, resulting
in the isolation of six guaianolid-type sesquiterpenes, chlorojanerin (1), 19-deoxychlorojanerin (2),
15-hydroxyjanerin (3), aguerin B (4), cynaropicrin (5), eleganin (6) (Figure 1); three flavonoids,
apigenin, 6-methoxyluteolin and jaceosidine; two glycosides, benzyl-1-O-β-d-glucoside and
3(Z)-hexenyl-1-O-β-d-glucoside; and the coumarin scopoletin. Compounds 1–6, the isolated flavonoids
and scopoletin were evaluated for their antiproliferative activities using the MTT assay. Human
gynecological malignant cell lines isolated from cervical (SiHa, HeLa) and female breast cancers
(MDA-MB-231) were utilized with regard to previous investigations where they were found to be
sensitive against metabolites of Cynareae plants [11,20–23]. In the present assay, chlorojanerin (1),
19-deoxychlorojanerin (2), aguerin B (4), cynaropicrin (5), and eleganin (6) were shown to have
noteworthy effects on all of the tested cell lines, while apigenin, jaceosidine, and 6-methoxyluteolin
were moderately active on HeLa cells.
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Figure 1. Structure of the isolated sesquiterpene lactones 1–6.
2. Results and Discussion
Antiproliferative testing of species belonging to tribe Cynareae [11] and previous screening
results on P. pyrrhoblepharus [12] initiated the present work, aiming at the identification of compounds
of P. pyrrhoblepharus with tumor cell growth inhibitory effect. The aerial parts of the plant were
extracted with MeOH at room temperature and, after concentration, the extract was partitioned
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between n-hexane, CHCl3, and H2O. The CHCl3 phase was subjected to a multistep chromatographic
separation and purification procedure including CC, VLC, RPC, gel filtration, and preparative TLC,
resulting in the isolation of pure compounds 1–6 (Figure 1), apigenin, 6-methoxyluteolin, jaceosidine,
benzyl-1-O-β-d-glucoside, 3(Z)-hexenyl-1-O-β-d-glucoside, and scopoletin. The structures of the
pure compounds were established by means of NMR and mass spectroscopy including 1H-NMR
(Figures S1–S10), JMOD, 1H,1H-COSY, HSQC, HMBC, and NOESY experiments and ESI-MS. For all
compounds, complete and unambiguous assignments of the NMR chemical shifts of protons and
carbons were achieved. The previously unpublished 1H- and 13C-NMR data of compounds 1–6 and
benzyl-1-O-β-d-glucoside in CD3OD, and jaceosidine in DMSO-d6 are listed in Tables 1 and 2, and in
Section 3. All compounds were isolated for the first time from P. pyrrhoblepharus.
Table 1. 1H-NMR data of compounds 1–6 [MeOH-d4, 500 MHz, δ ppm (J = Hz)].
1 2 3 4 5 6
1 3.56 ddd(9.6, 7.1, 7.1) 3.60 m
3.47 ddd
(9.5, 7.8, 7.2)
3.01 dd
(9.7, 7.2, 7.2)
3.01 ddd
(9.4, 7.1, 7.1)
2.96 ddd
(9.3, 7.3, 7.3)
2a 2.45 ddd(14.7, 7.1, 5.3)
2.49 ddd
(14.6, 7.0, 5.5) 2.40 m
2.10 ddd
(13.1, 7.2, 7.0)
2.09 ddd
(13.4, 7.1, 7.1)
2.10 ddd
(13.8, 7.3, 7.1)
2b 1.51 ddd(14.7, 10.0, 7.1)
1.54 dd
(14.6, 10.2, 7.0)
1.60 ddd
(14.0, 10.1, 7.8)
1.75 ddd
(13.1, 9.3, 7.2)
1.74 ddd
(13.4, 9.3, 7.1)
1.71 ddd
(13.8, 9.4, 7.3)
3 4.07 m 4.10 m 4.07 m 4.51 t (9.3, 7.0) 4.51 dd (9.3, 7.1) 4.48 dd (9.4, 7.1)
5 2.26 t (9.6) 2.28 dd (9.8, 9.2) 2.28 dd (10.2, 9.7) 2.90 t (10.1, 9.7) 2.91 dd (10.2, 9.4) 2.84 m
6 4.86 dd (9.6, 9.2) 4.91 dd (9.8, 9.2) 4.80 m 4.34 t (10.1) 4.35 t (10.2) 4.16 dd (10.3, 9.2)
7 3.15 br t (9.2) 3.17 m 3.20 m 3.26 m 3.28 m 2.87 m
8 5.12 m 5.12 m 5.12 m 5.12 m 5.15 m 3.87 ddd(9.3, 4.8, 4.3)
9a 2.67dd (15.0, 4.5) 2.71 dd (15.0, 4.8) 2.75 dd (14.5, 5.0) 2.73 dd (14.5, 4.9) 2.73 dd (14.5, 5.0) 2.67 dd (13.8, 4.8)
9b 2.38 br d (15.0) 2.42 br d (15.0) 2.38 dd (14.5, 3.2) 2.38 br d (14.5) 2.40 dd (14.5, 2.9) 2.25 dd (13.8, 4.3)
13a 6.07 d (2.8) 6.10 d (3.3) 6.11 d (3.0) 6.18 d (2.5) 6.13 d (3.1) 6.16 d (3.2)
13b 5.59 d (2.8) 5.57 d (3.3) 5.45 d (3.0) 5.59 d (2.5) 5.65 d (3.1) 6.14 d (3.2)
14a 5.08 br s 5.10 br s 5.12 br s 5.15 br s 5.17 br s 5.09 br s
14b 4.75 br s 4.77 br s 4.85 br s 4.91 br s 4.92 br s 4.97 br s
15a 4.14 d (11.7) 4.19 d (11.7) 4.02 d (11.8) 5.44 br s 5.44 br s 5.40 br s
15b 3.80 d (11.7) 3.83 d (11.7) 3.81 d (11.8) 5.34 br s 5.34 br s 5.31 br s
3′a 6.28 br s 6.18 br s 6.31 br s 6.13 d (2.5) 6.31 br s -
3′b 5.94 br s 5.73 br s 5.97 br s 5.73 d (2.5) 5.97 br s -
4′ 4.28 s (2H) 1.98 s 4.31 s (2H) 1.97 s 4.31s (2H) -
Table 2. 13C-NMR data of compounds 1–3, 5 and 6 (MeOH-d4, 125 MHz, δ ppm).
Position 1 2 3 5 6
1 48.73 48.95 46.90 46.18 45.93
2 39.80 40.02 39.15 40.01 40.01
3 76.94 76.99 77.81 74.14 74.11
4 85.77 85.84 85.82 154.04 154.26
5 59.39 59.64 57.53 52.02 51.81
6 78.45 78.52 78.84 80.30 80.87
7 47.43 47.60 48.17 48.45 51.66
8 75.47 75.57 75.63 75.63 73.07
9 35.74 35.80 37.48 37.66 42.84
10 144.71 145.05 144.68 144.04 144.63
11 139.11 139.52 139.23 139.71 140.53
12 170.97 170.84 171.11 171.21 172.0
13 122.53 122.01 122.45 122.39 122.95
14 117.71 117.48 117.27 118.15 117.03
15 50.04 50.08 64.35 112.72 112.15
1′ 166.65 167.86 166.55 166.55 -
2′ 141.61 137.76 141.91 141.92 -
3′ 126.25 126.92 125.97 125.97 -
4′ 61.53 18.31 61.62 61.63 -
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Chlorojanerin (1), 19-deoxychlorojanerin (2), 15-hydroxyjanerin (3), aguerin B (4), cynaropicrin
(5), eleganin (6), apigenin, 6-methoxyluteolin, jaceosidine, and scopoletin were investigated for their
antiproliferative activities on SiHa, HeLa, and MDA-MB-231 cells using the MTT assay.
Based on the determined antiproliferative activities (Table 3) it can be concluded that, with
the exception of compound 3, the isolated sesquiterpenes have comparable efficacy to or are even
more effective than the reference agent cisplatin against all of the cell tested cell lines. The highest
activities were found against the triple negative breast cancer model MDA-MB-231 (IC50 2.21–6.86 µM);
the chlorine-containing derivatives chlorojanerin (1) (IC50 2.21 µM) and 19-deoxychlorojanerin (2)
(IC50 2.88 µM) were more effective than the well-known sesquiterpene lactone cynaropicrin (5) (IC50
4.80 µM) [20]. The very close IC50 values of compound pairs 1 and 2, and 4 and 5 indicated that the side
chain methacrylate or 4-hydroxymethacrylate in position C-8 have no major influence on the activity.
Table 3. Antiproliferative activity of the isolated sesquiterpenoids, flavonoids, and coumarin.
Inhibition of Cell Proliferation (%) ± SEM [Calculated IC50 (µM)]
Compound Conc. SiHa HeLa MDA-MB-231
Chlorojanerin (1) 10 µM 82.10 ± 0.97 51.83 ± 2.43 90.55 ± 1.27
30 µM 92.93 ± 0.35 77.08 ± 0.80 92.00 ± 0.68
[6.71] [11.37] [2.21]
19-Deoxychlorojanerin (2) 10 µM 90.93 ± 1.32 96.17 ± 0.38 96.14 ± 0.51
30 µM 95.80 ± 0.15 96.14 ± 0.48 97.42 ± 0.36
[5.54] [4.86] [2.88]
15-Hydroxyjanerin (3) 10 µM <10 <10 <10
30 µM <10 <10 <10
Aguerin B (4) 10 µM 89.09 ± 1.54 28.87 ± 0.83 96.23 ± 0.45
30 µM 97.92 ± 0.41 97.50 ± 0.31 96.64 ± 0.71
[5.70] [12.64] [4.26]
Cynaropicrin (5) 10 µM 63.03 ± 1.25 34.36 ± 2.37 92.16 ± 0.68
30 µM 90.75 ± 0.55 68.26 ± 1.85 93.45 ± 0.27
[8.39] [12.99] [4.80]
Eleganin (6) 10 µM 64.97 ± 2.06 16.54 ± 1.48 89.44 ± 1.36
30 µM 90.89 ± 0.43 73.99 ± 1.68 92.09 ± 0.9
[7.57] [19.62] [6.86]
Apigenin 10 µM <10 * 18.81 ± 0.80 <10
30 µM 29.92 ± 1.75 70.43 ± 1.09 28.42 ± 1.04
Jaceosidine 10 µM 18.88 ± 2.99 <10 <10
30 µM 60.08 ± 0.74 75.18 ± 0.68 40.04 ± 1.68
6-Methoxyluteolin 10 µM 14.16 ± 1.49 88.00 ± 0.63 <10
30 µM 35.20 ± 2.08 93.74 ± 0.65 26.55 ± 2.12
[4.50]
Scopoletin 10 µM <10 <10 12.09 ± 2.59
30 µM 17.18 ± 2.18 <10 15.85 ± 1.85
Cisplatin 10 µM 88.64 ± 0.50 42.61 ± 2.33 67.51 ± 1.01
30 µM 90.18 ± 1.78 99.93 ± 0.26 87.75 ± 1.10
[7.84] [12.43] [3.74]
* Antiproliferative activities less than 10% are considered negligible and not given numerically.
Interestingly, 15-hydroxyjanerin (3), a close analogue of chlorojanerin (1), did not elicit any
considerable activity, indicating that 15-hydroxy group significantly decreases the antiproliferative
potency. The same observation was published by Iranshahy et al. [21], who reported 15-hydroxyjanerin
(3) (=aitchisonolide) to be ineffective on a set of human tumor cell lines, MCF-7, MCF-7/MX, PC-3,
HL-60, Jurkat, and HEK. The non-esterified sesquiterpene eleganin (6) exerted reasonable action
against the SiHa and MDA-MB-231 cells. Concerning the isolated flavonoids, jaceosidine exhibited a
modest action on all cell lines (i.e., 40–75% cell growth inhibition at 30 µM), the effects of apigenin and
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6-methoxyluteolin were similar but restricted to HeLa cells, while the only tested coumarin, scopoletin,
was ineffective on all cell lines.
In conclusion, this study demonstrates that P. pyrroblepharus is a rich source of sesquiterpene
lactones and flavonoids with antiproliferative activities. The chlorinated sesquiterpenes are particularly
considered promising and suitable for additional experiments in order to describe the potential
mechanism of the detected action. Sesquiterpene lactones represent a main focus of anticancer research;
their clinical relevance can be demonstrated by compounds newly introduced in clinical practice such
as arglabin, the dimethylamino adduct of which is a registered antitumor drug in the Republic of
Kazakhstan [24], and by compounds presently under clinical assessment (artemisinin, parthenolide,
and thapsigargin) [25]. Sesquiterpenes are known to exhibit considerable antitumor activity; it is
generally believed that the α-methylene-γ-lactone moiety is the functional group responsible for the
biological activity due to its interaction with biological nucleophiles. Their ability to inhibit DNA and
protein synthesis has been proven for many compounds. Cynaropicrin (5) was reported to increase the
relative expression levels of the important G2/mitosis checkpoint proteins, p21Waf1/Cip1, p-Tyr15-CDK1,
and cyclin B1, which may be related to the G2 cell cycle arrest in MDA-MB-231 breast cancer cells. This
compound downregulated the p-Ser473-Akt protein level without affecting the total Akt1 protein level.
Cynaropicrin did not affect caspase-3 activity [20].
Tumor cell selectivity was also investigated, and in the case of chlorojanerin (1), cynaropicrin (5),
and janerin, it was found that they are toxic to VERO cells (IC50 5.9–6.7 µg/mL) [26]. Cynaropicrin was
reported to reduce the 48 h-cell viability of human skin fibroblast Detroit 551 cells (IC50 9.11 µg/mL) [27].
15-Hydroxyjanerin was revealed to be inactive (IC50 > 50 µg/mL) against the HEK cell line [21].
In an anti-angiogenic study of sesquiterpene lactones, cynaropicrin (5), aguerin B (4), artemisinin,
thapsigargin, and parthenolide have demonstrated the ability to inhibit angiogenesis in vitro and in
ovo by inhibiting HUVEC proliferation, microvessel formation, and proliferation of human artery
endothelial cells. In addition, cynaropycrin and aguerin B exhibited remarkable angio-inhibitory effects
in the CAM assay [23].
3. Materials and Methods
3.1. General Procedures
NMR spectra were recorded in CDCl3 on a Bruker Avance DRX 500 spectrometer (Billerica, MA,
USA) at 500 MHz (1H) and 125 MHz (13C). In the 1H,1H-COSY, HSQC, and HMBC experiments,
gradient-enhanced versions were employed. Data were recorded and processed with the MestReNova
v6.0.2-5475 software (Santiago de Compostela, Spain). Chemical shifts are expressed in parts per
million, and coupling constant (J) values are reported in Hz. Mass spectra were recorded on a Thermo
Q Exactive mass spectrometer (Waltham, MA, USA) equipped with an ESI electrospray source. Data
were recorded and processed with the Thermo Xcalibur software (version 4.1, Waltham, MA, USA).
For column chromatography, silica gel 60 (0.063–0.200 mm) (70–230 mesh ASTM, Merck, Darmstadt,
Germany) was applied. For vacuum-liquid chromatography (VLC), silica gel (60 GF254, 15 µM, Merck)
was used, and for gelfiltration, we used Sephadex LH-20 (GE Healthcare, Uppsala, Sweden). Pre-coated
normal phase silica gel plates (60 F254, 0.25 mm, Merck) and reversed phase silica gel plates (60 RP-18
F254s, Merck) were used for thin-layer chromatographic (TLC) analyses and preparative TLC. Spots
were visualized by heating (105 ◦C) after spraying the plates with concentrated H2SO4. Rotational
planar chromatography (RPC) was performed on self-coated silica gel (60 GF254, 15 µM, Merck)
plates using a Chromatotron instrument (Harrison Research, T-Squared Technology, Inc., San Bruno,
CA, USA).
3.2. Plant Material
Psephellus pyrrhoblepharus (Boiss.) Wagenitz was collected during the flowering period from
rocky areas of Buzluk Cave, Harput, Elazıg˘, Turkey in 2012, at 1500 m. The plant was identified by
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Assoc. Prof. Ugur Cakilcioglu from Munzur University, Tunceli. A voucher specimen (No. 1464) was
deposited in the Herbarium of Department of Pharmacognosy, Faculty of Pharmacy, Ege University,
Izmir, Turkey.
3.3. Extraction and Isolation
The aerial parts of the plant were dried (750 g) and percolated with 20 L methanol. After
evaporation, the MeOH extract was suspended in 1 L MeOH:H2O (1:1) and extracted with n-hexane
(5 × 0.5 L) and CHCl3 (5 × 0.5 L). The CHCl3 extract was evaporated under reduced pressure to
dryness, yielding 19.1 g of oily material. This extract was chromatographed over a silica gel column
(800 g) using n-hexane:acetone:MeOH mixtures (9:1:0, 8:2:0, 7:3:0, 6:4:0, 5:5:0, 5:5:0.3, 1:1:0.1, 5:5:1, 5:5:2,
and 1:1:1, 800 mL each, volume of the fractions was 50 mL). Fractions collected were combined to
fractions A–D after TLC monitoring on silica gel 60 F254 using CHCl3:MeOH:acetone (9:2:1, 96:4:0),
n-hexane:EtOAc:EtOH (30:30:1), and toluene:EtOAc:HCOOH (5:4:1) as developing systems. Fraction A
(60 mg) was subjected to preparative silica gel TLC separation with toluene:EtOAc:MeOH 12:7:1 as the
developing system. Compound at Rf 0.35 was further purified on Sephadex LH-20 gel with a mixture
of acetone:MeOH 1:1, affording compound 4 (8.9 mg). Fraction B (162 mg) was subjected to preparative
TLC using the solvent system toluene:EtOAc:MeOH 12:7:1 to obtain compound 2 (Rf = 0.27, 12 mg).
Fraction C (3.9 g) was separated by vacuum-liquid chromatography (VLC) on silica gel with increasing
polarity of CHCl3:MeOH (10:0, 99:1, 98:2, 95:5, and 90:10, 50 mL each). Ten fractions (C1–10) were
obtained after TLC monitoring in this separation, all of them were subjected to Sephadex LH-20 gel
filtration using acetone:MeOH 1:1 as the eluent, yielding apigenin (14.5 mg) from fraction C1,2, and
after preparative TLC purification on silica gel using toluene:EtOAc:MeOH (12:7:1) as the developing
system, jaceosidine (6.7 mg) and scopoletin (4.1 mg) from fraction C3–5. In addition, compounds 1
(6.4 mg), 5 (25.3 mg) and 6 (13.6 mg) were isolated from fractions C3–7 in pure form by using rotational
planar chromatography (RPC) with toluene:EtOAc:MeOH 120:75:5 (100 mL), and 60:35:5 (100 mL) as
the developing solvent systems. Fraction D (2 g) was subjected to VLC with the gradient system of
n-hexane:EtOAc:MeOH (6:3:0.5, 6:3:1, 6:3:1.5, and 6:3:4, 200 mL each), resulting in subfractions I and
II. Subfraction I (0.7 g) was separated by RPC on silica gel using CH2Cl2:MeOH (10:0 and 9:1, 80 mL
each), affording 6-methoxyluteolin (3.7 mg). Subfraction II (1.1 g) was subjected to Sephadex LH-20 gel
filtration using acetone:MeOH 1:1 and then to RPC on silica gel using CH2Cl2:MeOH (10:0, 98:2, 96:4,
94:6, 92:8, 90:10, and 80:20, 100 mL each), resulting in compound 3 (18.3 mg) and a mixture of two
compounds. This mixture could be separated by preparative RP-TLC with methanol:water 7:3, and
HPLC with n-hexane:isopropanol 8:2 obtaining benzyl-1-O-β-d-glucoside (tR = 12.1 min, 3 mg) and
3(Z)-hexenoyl-1-O-β-d-glucoside (tR = 12.6 min, 6.7 mg).
Chlorojanerin (1): colorless amorphous solid; ESI-MS (positive): m/z 416 [M + H + NH3]+,
399 [M + H]+, 297 [M + H − C4H6O3]+, 279 [M + H − C4H6O3 −H2O]+; 1H-NMR (MeOH-d4, 500 MHz)
see Table 1; 13C-NMR (MeOH-d4, 125 MHz) see Table 2.
19-Deoxychlorojanerin (2): colorless amorphous solid; 1H-NMR (MeOH-d4, 500 MHz) see Table 1;
13C-NMR (MeOH-d4, 125 MHz) see Table 2.
15-Hydroxyjanerin (3): colorless amorphous solid; ESI-MS (positive): m/z 398 [M + H + NH3]+,
381 [M + H]+, 279 [M + H − C4H6O3]+, 261 [M + H − C4H6O3 − H2O]+, 243 [M + H − C4H6O3 − 2 ×
H2O]+; 1H-NMR (MeOH-d4, 500 MHz) see Table 1; 13C-NMR (MeOH-d4, 125 MHz) see Table 2.
Aguerin B (4): colorless oil; 1H-NMR (MeOH-d4, 500 MHz) see Table 1.
Cynaropicrin (5): colorless oil; 1H-NMR (MeOH-d4, 500 MHz) see Table 1; 13C-NMR (MeOH-d4,
125 MHz) see Table 2.
Eleganin (6): colorless oil; 1H-NMR (MeOH-d4, 500 MHz) see Table 1; 13C-NMR of 1–3, 5 and 6
(MeOH-d4, 125 MHz) see Table 2.
Jaceosidine: yellow powder; 1H-NMR (DMSO-d6, 500 MHz, δ ppm) 6.88 (1H, s, H-3), 6.60 (1H, s,
H-8), 7.55 (2H, m, H-2′, H-6′), 6.93 (1H, d, J = 8.5 Hz, H-5′), 3.75 (3H, s, 6-OCH3), 3.89 (3H, s, 3′-OCH3);
13C-NMR (DMSO-d6, 125 MHz, δ ppm) 163.6 (C-2), 102.7 (C-3), 182.1 (C-4), 152.7 (C-5), 131.4 (C-6),
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157.7 and 152.5 (C-7, C-9), 94.4 (C-8), 103.9 (C-10), 121.6 (C-1′), 110.2 (C-2′), 148.0 (C-3′), 150.7 (C-4′),
115.8 (C-5′), 120.3 (C-6′), 56.0 (3′-OCH3).
6-Methoxyluteolin: yellow powder; 1H-NMR and 13C-NMR (MeOH-d4, 500/125 MHz) data are
identical with the published data [28].
Apigenin and scopoletin were identified on the basis of the 1H-NMR spectra and by using
authentic materials.
Benzyl-1-O-β-d-glucoside: amorphous solid; 1H-NMR (MeOH-d4, 500 MHz, δ ppm) 7.42 (2H, d,
J = 7.3 Hz, H-2, H-6), 7.32 (2H, t, J = 7.3 Hz, H-3, H-5), 7.24 (1H, t, J = 7.2 Hz, H-4), 4.93 (1H, d,
J = 11.8 Hz, H-7a), 4.67 (1H, d, J = 11.8 Hz, H-7b), 4.35 (1H, d, J = 7.8 Hz, H-1′), 3.33 (1H, t, J = 8.2 Hz,
H-3′), 3.29 and 3.25 (1H and 2H, each m, H-2′, H-4′, H-5′), 3.89 (1H, d, J = 12.2 Hz, H-6′a), 3.69 (1H, dd,
J = 12.0 and 5.4 Hz, H-6′b); 13C-NMR (MeOH-d4, 125 MHz, δ ppm) 139.1 (C-1), 129.3 (C-2, C-6), 129.2
(C-3, C-5), 128.7 (C-4), 71.8 (C-7), 103.3 (C-1′), 75.2 (C-2′), 78.1 (C-3′), 71.7 (C-4′), 78.0 (C-5′), 62.8 (C-6′).
3-(Z)-Hexenyl-1-O-β-d-glucoside: amorphous solid; 1H-NMR and 13C-NMR (MeOH-d4,
500/125 MHz) identical with the published data [29].
3.4. Antiproliferative Assay
The antiproliferative effects of the isolated natural products were determined by means of the
MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]) assay on a panel of human
adherent cancer cells of gynecological origin. HeLa (HPV 18+ cervix carcinoma) and MDA-MB-231
(triple-negative breast cancer) cell lines were purchased from the European Collection of Cell Cultures
(Salisbury, UK) while SiHa (HPV 16+ cervix carcinoma) was obtained from the American Tissue
Culture Collection (Manassas, VA, USA). The cells were maintained in minimum essential medium
(MEM) supplemented with 10% fetal calf serum (FCS), 1% non-essential amino acids, and 1%
penicillin-streptomycin. All media and supplements for these experiments were obtained from Lonza
Group Ltd. (Basel, Switzerland). The cells were maintained at 37 ◦C in a humidified atmosphere
containing 5% CO2. The assays were performed as published previously [30]. Briefly, cells were
seeded onto 96-well plates at a density of 5000 cells/well and allowed to stand overnight, after which
the medium containing the tested compounds at 10 and 30 µM was added. After a 72-h incubation,
viability of the treated cells was determined by the addition of 20 µL of MTT solution (5 mg/mL).
The precipitated formazan crystals were solubilized in dimethylsulfoxide and the absorbance was
determined at 545 nm with an ELISA reader. In the case of the most effective compounds (i.e., exhibiting
at least 25% of cancer cell growth inhibition at 10 µM), the assays were repeated with a set of dilutions
(0.3–30 µg/mL) in order to determine the IC50 values by means of the computer program GraphPad
Prism 4.03 (San Diego, CA, USA). Two independent experiments were performed with five wells for
each condition. Cisplatin (Ebewe GmbH, Unterach, Austria), a clinically used anticancer agent, was
used as a reference compound.
4. Conclusions
Ethnopharmacological relevance of Psephellus species and accumulation of antitumor compounds
in genera Centaurea, Arctium, Cirsium, and Psephellus belonging to tribe Cynareae initiated the
present phytochemical investigation that resulted in the isolation and structural elucidation of
12 secondary metabolites. The isolated compounds were subjected to antiproliferative screening
using a set of human gynecological cancer cell lines, and several sesquiterpenes exhibited significant
antiproliferative activities against SiHa, HeLa, and MDA-MB-231 cells with IC50 values ranging from
2.21 to 19.62 µM. 19-Deoxychlorojanerin was first investigated in our experiment for antiproliferative
activity. Chlorojanerin, hydroxyjanerin, and eleganine were previously tested only against other
tumor cell lines, melanoma (SK-MEL, LOX-IMVI), epidermoid (KB), ductal (BT-549) and ovarian
carcinomas (SK-OV-3), non-small lung cancer (A549), breast (MCF-7), prostate (PC-3), and colorectal
(HCT-15) adenocarcinomas [22,26,31]. Hydroxyjanerin was investigated additionally on HeLa cells [32].
Cynaropicrin and aguerin B are well-investigated sesquiterpenes, whose antitumor effects have
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been studied in detail including their mechanism of action [20,22,23,31]. The most promising
compounds isolated in the present experiment from P. pyrrhoblepharus are the chlorinated sesquiterpenes
chlorojanerin (1) (IC50 from 2.21 to 11.37 µM) and 19-deoxychlorojanerin (2) (IC50 from 2.88 to 5.54 µM)
with higher activities than that of cynaropicrin; these compounds are attractive substrates for further
studies to explore their mechanism of action, selectivity, and safety profile.
Supplementary Materials: The following are available online at http://www.mdpi.com/1420-3049/24/17/3165/
s1, 1H-NMR spectra of compounds 1–6, and apigenin, 6-methoxyluteolin, jaceosidine and scopoletin are
available online.
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